Gender Disparity and Hormones in Cystic Fibrosis
Sponsor: University of Texas Southwestern Medical Center
Listed as NCT02036879, this EARLY_PHASE1 trial focuses on Cystic Fibrosis (CF) and remains completed. Sponsored by University of Texas Southwestern Medical Center, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Apr 2020 — Sep 2020 [monthly]
Completed EARLY_PHASE1
Phase: NA → EARLY_PHASE1
▶ Show 4 earlier versions
-
Feb 2019 — Apr 2020 [monthly]
Completed NA
Status: Recruiting → Completed
-
Nov 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .